EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases

Yi-Peng Gao, Can Hu, Min Hu, Wen-Sheng Dong, Kang Li, Yun-Jia Ye, Yu-Xin Hu, Xin Zhang

Cell Biology and Toxicology · 2024

DOI: 10.1007/s10565-024-09939-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology and Toxicology, 2024. Verfasst von Yi-Peng Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Hubei Key Laboratory of Metabolic and Chronic Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Metabolic Diseases, Cyclic AMP Response Element-Binding Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Natural Science Foundation of Hubei Province, the Fundamental Research Funds for the Central Universities, the Open Project of Hubei Key Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant advancements in cardiovascular and metabolic disease research have been made with the CREB3 protein family. Studies have revealed that members of this family are crucial in the development of these diseases, contributing to the regulation of lipid metabolism, inflammation, and vascular function. These studies provide useful information for future therapeutic strategies in cardiovascular and metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMetabolic DiseasesCyclic AMP Response Element-Binding ProteinHumansAnimalsLipid MetabolismMolecular Targeted TherapyInflammation

Stichwörter der Autor:innen

CREB3Cardiovascular and metabolic diseasesMetabolismTranscription factor

Substanzen

Cyclic AMP Response Element-Binding Protein

Autor:innen und Institutionen

  • Department of Geriatrics, Hubei Key Laboratory of Metabolic and Chronic Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Ultrasound, Clinical Research Center for Medical Imaging in Hubei Province, Hubei Province Key Laboratory of Molecular Imaging, Union Hospital, Tongji Medical College, Huazhong University of Science and Te…
  • Department of Cardiology, Hubei Key Laboratory of Metabolic and Chronic Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Geriatrics, Hubei Key Laboratory of Metabolic and Chronic Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, China. dr.zhangxin@whu.edu.cn.

Förderung

  • the Natural Science Foundation of Hubei Province
  • the Fundamental Research Funds for the Central Universities
  • the Open Project of Hubei Key Laboratory

Zitieren

APA

Gao, Y. P., Hu, C., Hu, M., Dong, W. S., Li, K., Ye, Y. J., Hu, Y. X., & Zhang, X. (2024). CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09939-5

Vancouver

Gao YP, Hu C, Hu M, Dong WS, Li K, Ye YJ, et al. CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases. Cell Biology and Toxicology. 2024. doi:10.1007/s10565-024-09939-5

BibTeX
@article{Gao2024,
  author = {Gao, Yi-Peng and Hu, Can and Hu, Min and Dong, Wen-Sheng and Li, Kang and Ye, Yun-Jia and Hu, Yu-Xin and Zhang, Xin},
  title = {CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases},
  journal = {Cell Biology and Toxicology},
  year = {2024},
  doi = {10.1007/s10565-024-09939-5}
}
Kostenlos starten →